Pulmonary Thromboendarterectomy

  • Michael M. MadaniEmail author
  • Jill R. Higgins


A small percentage of patients with acute pulmonary embolism go on to develop chronic thromboembolic pulmonary hypertension. The clot material is replaced by fibrotic scar like tissue, resulting in obstruction of the pulmonary vasculature. A potentially curative surgical procedure, pulmonary thromboendarterectomy, is the gold standard for treatment. Growing experience worldwide, and recent medical and surgical advancements have pushed the envelope in terms of treatment of this disease. This chapter provides a detailed account of indications, technical aspects and outcomes of pulmonary thromboendarterectomy.


Balloon pulmonary angioplasty Chronic thromboembolic pulmonary hypertension Pulmonary hypertension Pulmonary thromboendarterectomy Pulmonary vascular occlusive disease 


  1. 1.
    Riedel M, Stanek V, Widimsky J, Prerovsky I. Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151–8.CrossRefGoogle Scholar
  2. 2.
    Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Prog Surg. 2000;37:165–252.CrossRefGoogle Scholar
  3. 3.
    Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18:243–9.CrossRefGoogle Scholar
  4. 4.
    Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94:97–103.CrossRefGoogle Scholar
  5. 5.
    Moser KM, Houk VN, Jones RC, Hufnagel CC. Chronic, massive thrombotic obstruction of the pulmonary arteries: analysis of four operated cases. Circulation. 1965;32:377–85.CrossRefGoogle Scholar
  6. 6.
    Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53:1801915.CrossRefGoogle Scholar
  7. 7.
    Vuylsteke A, Sharples L, Charman G, et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomized controlled trial. Lancet. 2001;378:1379–87.CrossRefGoogle Scholar
  8. 8.
    Madani M, Ogo T, Simmonneau G. The changing landscape of chronic thromboembolic pulmonary hypertension management. Eur Respir Rev. 2017;26:170105.CrossRefGoogle Scholar
  9. 9.
    Cannon JE, Su L, Kiely DG, et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71.CrossRefGoogle Scholar
  10. 10.
    Ghofrani HA, D’Armini AM, Grimminger F, et al. (For the CHEST-1 group) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319–29.CrossRefGoogle Scholar
  11. 11.
    Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis. 1986;134:1241–5.PubMedGoogle Scholar
  12. 12.
    Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results of 150 pulmonary thrombo-endarterectomy operations over a 29 month period. J Thorac Cardiovasc Surg. 1993;106:116–27.CrossRefGoogle Scholar
  13. 13.
    Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J. 1992;5:334–42.PubMedGoogle Scholar
  14. 14.
    Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702–10.CrossRefGoogle Scholar
  15. 15.
    Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523–8.CrossRefGoogle Scholar
  16. 16.
    He J, Fang W. LvB et al. Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography. Nucl Med Commun. 2012;33:459–63.CrossRefGoogle Scholar
  17. 17.
    Mahmud S, Madani M, Kim H, et al. CTEPH: evolving therapeutic approaches for operable and inoperable disease. J Am Coll Cardiol. 2018;71:2468–86.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.UC San Diego Cardiovascular InstituteUniversity of California, San DiegoLa JollaUSA
  2. 2.Cardiac SurgeryUniversity of California, San DiegoLa JollaUSA
  3. 3.Cardiovascular and Thoracic SurgeryUniversity of California, San DiegoLa JollaUSA
  4. 4.UCSD Cardiovascular Institute—SurgeryUniversity of California, San DiegoLa JollaUSA
  5. 5.UCSD PTE ProgramUniversity of California, San DiegoLa JollaUSA

Personalised recommendations